CTLA4 and neoplasm: To assess immune response in the autochthonous lung tumors from KrasLSL-G12D/p53fl/fl mice treated with anti-PD-1/CTLA-4 or anti-PD-1/CTLA-4/Ly6C we probed for CD8 and quantified the percentage of CD8 cells within each tumor.